Search
for
Sort by
Research 211–240 of 1000+
- Alopecia areata update
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review
- Leydig Cell Hyperplasia and Adenomas in Mice Treated with Finasteride, a 5α-Reductase Inhibitor: A Possible Mechanism
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- KF19418, a new compound for hair growth promotion in vitro and in vivo mouse models
- Association of Alopecia Areata with Vitamin D and Calcium Levels: A Systematic Review and Meta-analysis
- Nurses' Drug Alert
- Androgen replacement therapy in women
- L-(+)-Tartaric Acid Minimally Affects the Viability or Molecular Signature but Increase the Expression of Selected Hair Growth Associated Genes in Human Dermal Papilla Cells
- 1315 An Integrated model of alopecia areata biomarkers highlights both Th1/Th2 upregulation, with stronger correlations between Th2 activation and disease severity
- 1371 FGF7-dependent inhibition of human hair growth byan osteopontin-derived peptide: A novel solution for hirsutism and hypertrichosis?
- Pediatric Dermatology Photoquiz: A 14-Year-Old Boy with Abrupt-Onset Hair Changes
- Reduced Ferritin, Folate and Vitamin B12 Levels in Female Patients Diagnosed With Telogen Effluvium
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- An updated review of the sebaceous gland and its role in health and diseases Part 2: Pathophysiological clinical disorders of sebaceous glands
- Molecular interactions of natural and synthetic steroids in female hamsters’ flank organs
- Hair Disorders
- Novel and Established Potassium Channel Openers Stimulate Hair Growth In Vitro: Implications for their Modes of Action in Hair Follicles
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling
- Topical calcipotriol vs narrowband ultraviolet B in treatment of alopecia areata: a randomized-controlled trial
- <i>Eclipta prostrata</i> promotes the induction of anagen, sustains the anagen phase through regulation of FGF-7 and FGF-5
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- A Prospective Study of the Prevalence of Nonclassical Congenital Adrenal Hyperplasia among Women Presenting with Hyperandrogenic Symptoms and Signs
- Dermatological adverse events with taxane chemotherapy
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Extracellular vesicles derived from MSCs activates dermal papilla cell in vitro and promotes hair follicle conversion from telogen to anagen in mice
- Ovarian Morphology Is a Marker of Heritable Biochemical Traits in Sisters with Polycystic Ovaries
- Approach to the adult female patient with diffuse nonscarring alopecia
- Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review